| Literature DB >> 28053787 |
Matthias Jacobi1, Nikolaus Reischl2, Karolin Rönn3, Robert A Magnusson4, Emanuel Gautier5, Roland P Jakob6.
Abstract
Background. The injured anterior cruciate ligament (ACL) has a limited healing capacity leading to persisting instability. Hypothesis/Purpose. To study if the application of a brace, producing a dynamic posterior drawer force, after acute ACL injury reduces initial instability. Study Design. Cohort study. Methods. Patients treated with the ACL-Jack brace were compared to controls treated with primary ACL reconstruction und controls treated nonsurgically with functional rehabilitation. Measurements included anterior laxity (Rolimeter), clinical scores (Lysholm, Tegner, and IKDC), and MRI evaluation. Patients were followed up to 24 months. Results. Patients treated with the ACL-Jack brace showed a significant improvement of anterior knee laxity comparable to patients treated with ACL reconstruction, whereas laxity persisted after nonsurgical functional rehabilitation. The failure risk (secondary reconstruction necessary) of the ACL-Jack group was however 21% (18 of 86) within 24 months. Clinical scores were similar in all treatment groups. Conclusion. Treatment of acute ACL tears with the ACL-Jack brace leads to improved anterior knee laxity compared to nonsurgical treatment with functional rehabilitation.Entities:
Year: 2016 PMID: 28053787 PMCID: PMC5174171 DOI: 10.1155/2016/1609067
Source DB: PubMed Journal: Adv Orthop ISSN: 2090-3464
Figure 1Photograph of the ACL-Jack brace.
Figure 2Diagram showing that the brace consists of an upper thigh (1) and a leg part (2) connected through a hinge at the ankle (3) and knee (4). The load is applied through a relocatable load arm (5) from the hinge to the leg part, which rotates around the distal hinge (3). F = force.
Baseline data of the ACL-Jack group, the functional treatment group, and the primary ACL reconstruction group.
| ACL-Jack | Functional treatment | Primary ACL reconstruction |
| ||
|---|---|---|---|---|---|
| Included patients | |||||
|
| |||||
| Patients |
| 86 | 20 | 20 | |
| Dropouts (total) |
| 20 (23%) | 6 (30%) | 0 | |
| (i) Failures |
| 18 (20.9%) | 6 (30%) | 0 | |
| (ii) Lost to follow up |
| 2 (2%) | 0 | 0 | |
| Age | years | 32 ± 14 (14–74) | 35 ± 10 (21–48) | 23 ± 7 (15–40) | 0.00002 |
| Sex | M/F | 52/33 | 13/7 | 14/6 | |
| Side | R/L | 48/37 | 8/12 | 12/8 | |
| Meniscus tear |
| 11 (12%) | 0 | 6 (30%) | |
| ACL displaced |
| 28 (33%) | 6 (30%) | — | |
| Injury to treatment | days | 14 ± 10 (10–21) | — | 37 ± 26 (10–89) | 0.0001 |
|
| |||||
| Analyzed patients | |||||
|
| |||||
| Patients |
| 66 | 14 | 20 | |
| Sex | M/F | 36/30 | 8/6 | 14/6 | |
| Side | R/L | 38/28 | 5/9 | 12/8 | |
| Meniscus tear |
| 9 (14%) | 0 (0%) | 6 (30%) | |
| ACL displaced |
| 23 (27%) | 4 (29%) | — | |
| Injury to treatment | days | 14 ± 8 (10–21) | — | 37 ± 26 (10–89) | 0.0001 |
Comparative data of successfully treated and failed patients within the ACL-Jack group.
| ACL-Jack group | ||||
|---|---|---|---|---|
| Successful | Failures |
| ||
| Patients |
| 66 | 18 | |
| Age | Years | 34 ± 15 (14–74) | 24 ± 12 (15–57) | 0.00002 |
| Sex | M/F | 36/31 | 16/2 | |
| Meniscus tear |
| 9 (14%) | 2 (11%) | n.s. |
| ACL displaced |
| 23 (27%) | 5 (28%) | n.s. |
| Injury to treatment | Days | 13 ± 5 (3–21) | 14 ± 7 (5–21) | n.s. |
Clinical outcome and side-to-side ACL stability (Rolimeter) of the ACL-Jack (successful), functional treatment (successful), and primary ACL reconstruction group.
| ACL-Jack |
| Functional treatment |
| Primary ACL reconstruction |
|
| |
|---|---|---|---|---|---|---|---|
| Tegner preinjury | 6.6 ± 2 (4–10) | <0.00001 | 5.1 ± 1.4 (2–6) | <0.00001 | 8.6 ± 1.3 (5–10) | 0.00026 | 0.00002 |
| Tegner 12 months | 5.6 ± 2.1 (3–10) | 3.4 ± 0.9 (2–5) | 7.7 ± 1.8 (4–10) | <0.000001 | |||
| Tegner 24 months | 5.9 ± 2 (3–10) | 3.5 ± 1 (2–5) | 7.9 ± 1.7 (4–10) | <0.000001 | |||
|
| |||||||
| Lysholm preinjury | 99.7 ± 1.2 (95–100) | <0.00001 | 100 ± 0 (100-100) | <0.00001 | 98.6 ± 2.4 (94–100) | <0.00001 | 0.047 |
| Lysholm 12 months | 92.8 ± 8.6 (67–100) | 93.7 ± 6.3 (79–100) | 88.4 ± 6.9 (79–100) | 0.055 | |||
| Lysholm 24 months | 93.3 ± 8.3 (67–100) | 92.7 ± 7.4 (67–100) | 89.1 ± 7.7 (74–100) | 0.034 | |||
|
| |||||||
| IKDC preinjury | 96.5 ± 5.2 (72–100) | <0.00001 | 97 ± 3.5 (91–100) | <0.00001 | 98.4 ± 3 (90–100) | <0.00001 | 0.17 |
| IKDC 12 months | 88.7 ± 9.4 (58–100) | 85.2 ± 9.1 (66–100) | 88.1 ± 8.4 (72–100) | 0.72 | |||
| IKDC 24 months | 90 ± 8.7 (69–100) | 86.4 ± 11 (66–100) | 88.3 ± 8.6 (74–100) | 0.37 | |||
|
| |||||||
| Diff injury (mm) | 4.3 ± 2 (3–11) | <0.00001 | 4.5 ± 2.5 (2–10) | 0.71 | 4.6 ± 0.8 (4–6) | <0.0001 | 0.32 |
| Diff 6 months (mm) | 0.9 ± 1.8 (0–4.5) | — | — | — | |||
| Diff 12 months (mm) | 1 ± 1.4 (0–4) | — | — | — | |||
| Diff 24 months (mm) | 1.1 ± 2 (0–5) | 4.8 ± 2.4 (2–8) | 0.9 ± 1.1 (0–3) | 0.000002 | |||
Figure 3Bars comparing the initial (0) and follow-up (24-month) anterior drawer (bilateral comparison) measured with the Rolimeter of the three treatment groups. Significance is reported in Table 3.
Figure 4Initial and follow-up MRI six months after treatment with the ACL-Jack brace.